Merck
MRK
#61
Rank
S$320.39 B
Marketcap
S$128.27
Share price
-0.79%
Change (1 day)
-5.37%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): S$9.97

According to Merck's latest financial reports the company's current EPS (TTM) is S$9.85. In 2024 the company made an earnings per share (EPS) of S$8.76 an increase over its 2023 EPS that were of S$0.20.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$9.9713.79%
2024S$8.764308.46%
2023S$0.20-97.32%
2022S$7.4310.92%
2021S$6.7084.68%
2020S$3.63-27.2%
2019S$4.9863.44%
2018S$3.05151.11%
2017S$1.21-54.58%
2016S$2.6730.21%
2015S$2.05-61.99%
2014S$5.40180.51%
2013S$1.92-31.82%
2012S$2.826.62%
2011S$2.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$2.23-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$13.54 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$26.60 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$3.85-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$4.80-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
S$4.66-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$0.82-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
S$9.54-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
S$10.45 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$16.89 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA